Table 1 Clinical characteristics of the patients at admission (n = 168)
Variable | Value median (IQR) |
|---|---|
Demographic variables | |
Age, y | 77 (72–84) |
Gender | |
Female | 55 (32.7%) |
Male | 113 (67.3%) |
Smoking | |
ex-smoker | 116 (69.0%) |
never-smoker | 52 (31.0%) |
Disease | |
Pneumonia | 86 |
Lung Cancer | 34 |
ILD | 30 |
COPD | 4 |
Pneumothorax | 3 |
Asthma | 3 |
Pulmonary malignant lymphoma | 2 |
Pulmonary embolism | 2 |
Hemoptysis due to bronchiectasis | 2 |
Pulmonary artery hypertension | 1 |
Allergy to antituberculosis drugs | 1 |
Outcome | |
death | 39 (23.2%) |
survival | 129 (76.8%) |
Vital signs at admission | |
SpO2/FiO2 rate | 419 (342–452) |
Respiratory rate, /min | 20 (18–24) |
ROX index | 20.0 (14.8–25.0) |
SBP, mmHg | 126 (109–143) |
DBP, mmHg | 76 (64–87) |
BMI, kg/m² (N = 152) | 21 (18–23) |
Laboratory variables | |
Hemoglobin, g/dL | 11.8 (10.4–13.5) |
WBC, /µL | 9100 (7300–12800) |
Neutrophil count, /µL | 7117(5425–10884) |
Lymphocyte count, /µL | 1050 (673–1366) |
NLR | 7.3 (4.3–13.1) |
CRP, mg/dL | 6.5 (2.2–12.3) |
Albumin, g/dL | 3.2 (2.7–3.5) |
GPS (0/1/2) | 16 (9.5%)/44 (26.2%)/108 (64.3%) |
D-dimer, µg/mL(N = 158) | 2.7 (1.7–5.3) |
Charlson Comorbidity Index | 6 (5–9) |
Clinical Frailty Scale | 4 (3–6) |
MNA-SF score | 9 (7–11) |
MNA SF nutritional status | |
MNA-SF < 11 | 108 (64.3%) |
MNA-SF ≧ 11 | 60 (35.7%) |